Li, Huiqi
Xu, Yiyi
Kirui, Brian
Santosa, Ailiana
Nyberg, Fredrik
Funding for this research was provided by:
University of Gothenburg
Article History
Received: 15 November 2024
Accepted: 1 March 2026
First Online: 11 April 2026
Declarations
:
: The study is part of the SCIFI-PEARL project, and ethical approval was obtained from the Swedish Ethical Review Authority (Reference number 2020 − 01800 with subsequent amendments). As it is a register-based study, individual consent from participants was not required. The study was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: FN, AS, HL report participation in a research project funded by Bayer (regulator-mandated phase IV study), with funds paid to the University of Gothenburg where they are employed (no personal fees) and with no relation to the work reported here. FN owns some AstraZeneca shares. All other authors have no competing interests to disclose.